Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114884) titled 'Effectiveness and safety of Tanreqing Injection for Preventing ICU pneumonia caused by multidrug-resistant bacteria: A randomised controlled trial' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: West China Hospital, Sichuan University
Condition:
Multidrug-resistant bacterial pneumonia
Intervention:
Experimental Group:Tanreqing Injection
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-01
Target Sample Size: Experimental Group:60;Control Group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/s...